Clinical trial · Interventional
Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne
An Open Label Pilot Clinical Trial on the Efficacy and Safety of ProOxy Facial Spray (Topical 15% Oxygen Solution) in the Treatment of Moderate Facial Acne Vulgaris Among Filipino Patients
NCT01682200CI-TRIAL-00007986completedPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was conducted to determine the effects and side effects of ProOxy facial spray in the treatment of acne.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acne Vulgaris | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ProOxy | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ProOxy, Effects and Side Effects in treating acne
- description
- Patients are instructed to clean the face with ProOxy facial cleanser and then spray on the face wet enough but not dripping twice daily (upon waking up and before bedtime) for 3 months.
- interventionNames
- Drug: ProOxy
Primary outcomes (1)
- measure
- Changes in the appearances,sizes of the acne lesions as well as the disappearance of acne on the face.
- timeFrame
- 4,8,12 weeks post application of the spray
- description
- Upon acceptance,pictures are taken and acne lesions are identified and counted and after 4,8, and 12 weeks during and after application of ProOxy.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * patients with acne on their faces only * patients who are at least 18 years of age * patients who have normal and disease free skin at the dorsal surface of the upper arm. * patients who are willing to follow instructions on both the Patch Test Part one and Part Two procedures and to follow scheduled visits. Exclusion Criteria * patients with systemic illnesses(such as but not limited to heart disease, hypertension, diabetes, cancer, liver disease, kidney disease) * patients with very dark skin color, Fitzpatrick skin type V-VI, who are prone to post=inflammatory hyperpigmentation. * patients with intake of oral medications including glucocorticoids or any immuno-suppressants or who have undergone ultraviolet phototherapy for the past 2 weeks prior to the patch test. * patients with history of contact dermatitis, dermatographism or anaphylaxis. * patients with history of eczematous and inflammatory dermatitis, seborrheic dermatitis and psoriasis.
References
Publications (0)
Data not yet available
No reference posted for this study.